Sherwin K B Sy

Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 23

Top Venues

Clinical pharmacokinetics

Pharmaceutics

British journal of clinical pharmacology

Cancer chemotherapy and pharmacology

University of Florida (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

University of Florida

United States

PHD :: Pharmaceutical Sciences

Publications

Yan Ji, Sherwin K B Sy
Utility and impact of quantitative pharmacology on dose selection and clinical development of immuno-oncology therapy. Cancer chemotherapy and pharmacology (2024)
Yan Ji, Sherwin K B Sy
Utility and impact of quantitative pharmacology on dose selection and clinical development of immuno-oncology therapy. Cancer chemotherapy and pharmacology 93 (4) (2024)
Yan Ji, Sherwin K B Sy
Utility and impact of quantitative pharmacology on dose selection and clinical development of immuno-oncology therapy. Cancer chemotherapy and pharmacology 93 (4) (2024)
Frederico Severino Martins, José Eduardo Severino Martins, Patricia Severino, Pieter Annaert, Sherwin K B Sy
Physiologically-based pharmacokinetic modeling to inform combination dosing regimens of ceftaroline and daptomycin in special populations. British journal of clinical pharmacology (2023)
Jiayuan Zhang, Mengyuan Wu, Shuo Diao, Shixing Zhu, Chu Song, Jiali Yue, Frederico S Martins, Peijuan Zhu, Zhihua Lv, Yuanqi Zhu, Mingming Yu, Sherwin K B Sy
Pharmacokinetic/Pharmacodynamic Evaluation of Aztreonam/Amoxicillin/Clavulanate Combination against New Delhi Metallo-β-Lactamase and Serine-β-Lactamase Co-Producing Escherichia coli and Klebsiella pneumoniae . Pharmaceutics 15 (1) (2023)
Jiayuan Zhang, Mengyuan Wu, Shuo Diao, Shixing Zhu, Chu Song, Jiali Yue, Frederico S Martins, Peijuan Zhu, Zhihua Lv, Yuanqi Zhu, Mingming Yu, Sherwin K B Sy
Pharmacokinetic/Pharmacodynamic Evaluation of Aztreonam/Amoxicillin/Clavulanate Combination against New Delhi Metallo-β-Lactamase and Serine-β-Lactamase Co-Producing Escherichia coli and Klebsiella pneumoniae . Pharmaceutics 15 (1) (2023)
Jiayuan Zhang, Hai Yang, Lei Zhang, Zhihua Lv, Mingming Yu, Sherwin K B Sy, Yuanchao Zhan
Comparative metabolomics reveal key pathways associated with the synergistic activities of aztreonam and clavulanate combination against multidrug-resistant Escherichia coli . mSystems (2023)
Jiayuan Zhang, Mengyuan Wu, Shuo Diao, Shixing Zhu, Chu Song, Jiali Yue, Frederico S Martins, Peijuan Zhu, Zhihua Lv, Yuanqi Zhu, Mingming Yu, Sherwin K B Sy
Pharmacokinetic/Pharmacodynamic Evaluation of Aztreonam/Amoxicillin/Clavulanate Combination against New Delhi Metallo-β-Lactamase and Serine-β-Lactamase Co-Producing Escherichia coli and Klebsiella pneumoniae . Pharmaceutics 15 (1) (2023)
Jiayuan Zhang, Mengyuan Wu, Shuo Diao, Shixing Zhu, Chu Song, Jiali Yue, Frederico S Martins, Peijuan Zhu, Zhihua Lv, Yuanqi Zhu, Mingming Yu, Sherwin K B Sy
Pharmacokinetic/Pharmacodynamic Evaluation of Aztreonam/Amoxicillin/Clavulanate Combination against New Delhi Metallo-β-Lactamase and Serine-β-Lactamase Co-Producing Escherichia coli and Klebsiella pneumoniae . Pharmaceutics 15 (1) (2023)
Jiayuan Zhang, Mengyuan Wu, Shuo Diao, Shixing Zhu, Chu Song, Jiali Yue, Frederico S Martins, Peijuan Zhu, Zhihua Lv, Yuanqi Zhu, Mingming Yu, Sherwin K B Sy
Pharmacokinetic/Pharmacodynamic Evaluation of Aztreonam/Amoxicillin/Clavulanate Combination against New Delhi Metallo-β-Lactamase and Serine-β-Lactamase Co-Producing Escherichia coli and Klebsiella pneumoniae . Pharmaceutics 15 (1) (2023)
Sherwin K B Sy, Chiaki Tanaka, Kai Grosch
Population Pharmacokinetics and Pharmacodynamics of Crizanlizumab in Healthy Subjects and Patients with Sickle Cell Disease. Clinical pharmacokinetics 62 (2) (2022)
Francois Pierre Combes, Ying Fei Li, Matthias Hoch, Sebastien Lorenzo, Yu-Yun Ho, Sherwin K B Sy
Exposure-Efficacy Analysis of Asciminib in Philadelphia Chromosome-Positive Chronic Myeloid Leukemia in Chronic Phase. Clinical pharmacology and therapeutics 112 (5) (2022)
Ying Fei Li, Francois Pierre Combes, Matthias Hoch, Sebastien Lorenzo, Sherwin K B Sy, Yu-Yun Ho
Population Pharmacokinetics of Asciminib in Tyrosine Kinase Inhibitor-Treated Patients with Philadelphia Chromosome-Positive Chronic Myeloid Leukemia in Chronic and Acute Phases. Clinical pharmacokinetics 61 (10) (2022)
Shixing Zhu, Jiayuan Zhang, Zhihua Lv, Peijuan Zhu, Charles Oo, Mingming Yu, Sherwin K B Sy
Prediction of Tissue Exposures of Meropenem, Colistin, and Sulbactam in Pediatrics Using Physiologically Based Pharmacokinetic Modeling. Clinical pharmacokinetics 61 (10) (2022)
Sherwin K B Sy, Chiaki Tanaka, Kai Grosch
Population Pharmacokinetics and Pharmacodynamics of Crizanlizumab in Healthy Subjects and Patients with Sickle Cell Disease. Clinical pharmacokinetics 62 (2) (2022)
Yan Ji, Deborah Knee, Xinhui Chen, Anhthu Dang, Jennifer Mataraza, Babette Wolf, Sherwin K B Sy
Model-informed drug development for immuno-oncology agonistic anti-GITR antibody GWN323: Dose selection based on MABEL and biologically active dose. Clinical and translational science 15 (9) (2022)
Sherwin K B Sy, Chiaki Tanaka, Kai Grosch
Population Pharmacokinetics and Pharmacodynamics of Crizanlizumab in Healthy Subjects and Patients with Sickle Cell Disease. Clinical pharmacokinetics (2022)
Kun Feng, Nan Jia, Peijuan Zhu, Serubbabel Sy, Yanfei Liu, Dandan Dong, Shixing Zhu, Jiayuan Zhang, Yuwei Liu, Frederico S Martins, Hugh Gong, Zhihua Lv, Mingming Yu, Sherwin K B Sy, Yuanqi Zhu
Aztreonam/avibactam effect on pharmacodynamic indices for mutant selection of Escherichia coli and Klebsiella pneumoniae harbouring serine- and New Delhi metallo-β-lactamases. The Journal of antimicrobial chemotherapy 76 (11) (2021)
Sherwin K B Sy, Luning Zhuang, Serubbabel Sy, Hartmut Derendorf
Clinical Pharmacokinetics and Pharmacodynamics of Ceftazidime-Avibactam Combination: A Model-Informed Strategy for its Clinical Development. Clinical pharmacokinetics 58 (5) (2020)
Frederico S Martins, Peijuan Zhu, M Tobias Heinrichs, Sherwin K B Sy
Physiologically based pharmacokinetic-pharmacodynamic evaluation of meropenem plus fosfomycin in paediatrics. British journal of clinical pharmacology 87 (3) (2020)
Carla Biesdorf, Frederico Severino Martins, Sherwin K B Sy, Andrea Diniz
Physiologically-based pharmacokinetics of ziprasidone in pregnant women. British journal of clinical pharmacology 85 (5) (2019)
James Albiero, Josmar Mazucheli, Juliana Pimenta Dos Reis Barros, Marcia Maria Dos Anjos Szczerepa, Sheila Alexandra Belini Nishiyama, Floristher Elaine Carrara-Marroni, Serubbabel Sy, Matthew Fidler, Sherwin K B Sy, Maria Cristina Bronharo Tognim
Pharmacodynamic Attainment of the Synergism of Meropenem and Fosfomycin Combination against Pseudomonas aeruginosa Producing Metallo-β-Lactamase. Antimicrobial agents and chemotherapy 63 (6) (2019)
Nayara Helisandra Fedrigo, Josmar Mazucheli, James Albiero, Danielle Rosani Shinohara, Fernanda Gomes Lodi, Ana Cristina Dos Santos Machado, Sherwin K B Sy, Maria Cristina Bronharo Tognim
Pharmacodynamic Evaluation of Fosfomycin against Escherichia coli and Klebsiella spp. from Urinary Tract Infections and the Influence of pH on Fosfomycin Activities. Antimicrobial agents and chemotherapy 61 (8) (2017)

Sherwin K B Sy.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Sherwin K B Sy